MTL 001Alternative Names: MTL-001
Latest Information Update: 13 Jul 2016
At a glance
- Originator Morvus Technology
- Class Antiparasitics
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Leishmaniasis; Trypanosomiasis
Most Recent Events
- 13 Jul 2016 Preclinical trials in Trypanosomiasis in United Kingdom (unspecified route)
- 13 Jul 2016 Preclinical trials in Leishmaniasis in United Kingdom (unspecified route)